Inside the Core of Sterile Manufacturing: Zeptide Pharma’s Cleanroom Operations

Zeptide Cleanroom Architecture

In the production of sterile injectable medications, the manufacturing environment is just as critical as the drug formulation itself. Even a single microscopic particle or microorganism can compromise an entire batch, putting patient lives at risk.

To meet our obligations as a premier CDMO and trusted partner for government and commercial healthcare supply chains, Zeptide Pharma operates state-of-the-art cleanroom facilities. Our sterile fill-finish suites are engineered with uncompromising precision, ensuring absolute environmental control from the moment materials enter the suite until the sealed vials, syringes, or auto-injector cartridges exit.

Here is an inside look at the modern cleanroom features and the rigorous operational protocols we execute during and after sterile drug manufacturing.

ISO-7 and ISO-5 Environments

Zeptide Pharma’s cleanroom facilities are designed using a "defense-in-depth" approach, utilizing cascading zones of increasing cleanliness to protect the highly sensitive core where the drug is exposed.

ISO-7 (Grade C and B) Background Environments

The rooms surrounding the critical filling zones operate under ISO-7 standards. These areas are used for material staging, compounding, and final personnel gowning.

• Pressure Cascades: These rooms maintain a positive pressure differential relative to the outside corridors. Air always flows outward from the cleanest areas to the less clean areas, preventing external contaminants from entering.
• High-Efficiency Particulate Air (HEPA) Filtration: Ceiling-mounted HEPA filters replace the room air up to 60 to 90 times per hour, aggressively scrubbing the environment of airborne particles.
• Sanitary Design: All surfaces feature epoxy flooring, flush-mounted lighting, and coved (rounded) corners where the walls meet the floor and ceiling. This eliminates 90-degree angles where dust or microbes could accumulate.

ISO-5 (Grade A) Critical Processing Zones

The actual filling of the sterile liquid into its primary container takes place inside ISO-5 environments, which represent the pinnacle of cleanroom technology.

• Unidirectional Laminar Airflow: Above the filling line, continuous HEPA-filtered air flows straight down at a controlled velocity of approximately 0.45 meters per second. This unidirectional flow acts as an invisible curtain, physically sweeping particles away from the exposed drug.
• Closed Isolator Technology: Zeptide Pharma utilizes advanced robotic isolators. These fully enclosed systems physically separate the human operators from the sterile filling line using thick glass walls and integrated glove ports, virtually eliminating the risk of human-borne contamination.

Operations During Sterile Manufacturing

Maintaining these pristine environments requires flawless operational discipline while a batch is actively being produced.

• Stringent Gowning Protocols: Operators undergo a rigorous, multi-step gowning process before entering the cleanroom. They wear pre-sterilized, lint-free Tyvek coveralls, hoods, masks, double gloves, and boots. No exposed skin is permitted.
• Controlled Personnel Movement: Humans are the primary source of particle generation in a cleanroom. Operators are trained to move slowly and deliberately. Interventions on the filling line are strictly minimized and performed only through isolator glove ports using sterilized tools.
• Active Environmental Monitoring: During the fill, automated systems continuously sample the air for viable (living microbes) and non-viable (dust/debris) particles. Agar settle plates and active air samplers are positioned directly adjacent to the filling needles to prove the environment remained sterile for the exact duration of the batch.

Post-Production Turnaround and Decontamination

Once the batch is sealed and exits the cleanroom, an intensive decontamination and turnaround protocol begins to prepare the suite for the next product.

• Comprehensive Line Clearance: Every component, document, and tool associated with the finished batch is completely removed from the suite to prevent any possibility of cross-contamination or mix-ups with the next product.
• Rotational Cleaning and Disinfection: Operators manually clean all surfaces using specialized, sterile cleaning agents. To prevent bacteria and fungi from developing resistance, we rotate between different broad-spectrum disinfectants and highly active sporicidal agents.
• Vaporized Hydrogen Peroxide (VHP) Bio-Decontamination: For the ISO-5 isolators, manual cleaning is not enough. The automated VHP system vaporizes hydrogen peroxide and circulates it throughout the closed filling line. This gas penetrates every microscopic crevice, destroying bacterial spores and providing a validated, 6-log reduction in bioburden.
• Aeration and Release: After VHP exposure, the system automatically aerates the isolator, breaking the hydrogen peroxide down into harmless water vapor and oxygen. Environmental monitoring systems take baseline readings to confirm the suite has returned to pristine ISO-5 and ISO-7 standards before the next batch can begin.

To establish a Professional Partnership:

Contact MayMag Biologics (Formerly Tirzepatide Pharma / Zeptide Pharma)

Partner with a premier USA-based, FDA-registered 503B/506E CDMO and IND facility. As a leading sterile API manufacturer and large-scale industrial supplier, we provide comprehensive manufacturing solutions for a wide range of critical care and specialized therapeutics, including:

• Diabetic Care & Biosimilars: Insulin 70/30 pens, glargine, and advanced biosimilars.
• Injectables & Auto-Pens: Auto-injector medications and epinephrine delivery systems.
• Specialized Treatments: Weight-loss therapies, nasal sprays, and ophthalmic products.
• Essential Preparations: Sterile and bacteriostatic waters.